T A B L E O F C O N T E N

Background
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic and potentially life threatening condition resulting from excessive ovarian stimulation. Reported incidence varies from 1% to 10% of in vitro fertilization (IVF) cycles. The factors contributing to OHSS have not been completely explained. The release of vasoactive substances secreted by the ovaries under human chorionic gonadotrophin (hCG) stimulation may play a key role in triggering this syndrome. This condition is characterised by a massive shift of fluid from the intra-vascular compartment to the third space resulting in profound intra-vascular depletion and haemoconcentration.
Objectives
To assess the effect of withholding gonadotrophins (coasting) on the prevention of ovarian hyperstimulation syndrome in assisted reproduction cycles.
Search strategy
For the update of this review we searched the Cochrane Menstrual Disorders and Subfertility Review Group Trials Register (July 2010), CENTRAL (inception to July 2010), MEDLINE (PubMed) (inception to July 2010), and EMBASE (inception to July 2010) for randomised controlled trials (RCTs) in which coasting was used to prevent OHSS.
Selection criteria
Only randomised controlled trials (RCTs) in which coasting was used to prevent OHSS were included.
Data collection and analysis
Two review authors independently selected trials and extracted data. Disagreements were resolved by discussion. Study authors were contacted to request additional information or missing data. The intervention comparisons were coasting versus early unilateral follicular aspiration (EUFA), no coasting or other interventions. Statistical analysis was performed in accordance with the Cochrane Menstrual Disorders and Subfertility Group guidelines.
Main results
This updated review identified 16 studies of which four met the inclusion criteria. There was no evidence of a difference in the incidence of moderate and severe OHSS (odds ratio (OR) 0.53, 95% CI 0.23 to 1.23), live birth (OR 0.48, 95% CI 0.14 to 1.62; P = 0.24) or in the clinical pregnancy rate (OR 0.69, 95% CI 0.44 to 1.08) between the groups. Significantly fewer oocytes were retrieved in coasting groups compared with GnRHa (OR -2.44, 95% CI -4.30 to -0.58; P = 0.01) or no coasting (OR -3.92, 95% CI -4.47 to -3.37; P < 0.0001). Data for coasting versus EUFA were not pooled for number of oocytes retrieved due to heterogeneity (I 2 = 87%).
Authors' conclusions
There was no evidence to suggest a benefit of using coasting to prevent OHSS compared with no coasting or other interventions.
P L A I N L A N G U A G E S U M M A R Y
Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndrome (OHSS) is a complication of using hormones to induce ovulation (the release of eggs) in IVF (in vitro fertilization). The hormones can sometimes over-stimulate the ovaries. Severe OHSS can be life threatening. One method used to try and reduce the risk of OHSS is 'coasting' or 'prolonged coasting'. This involves withholding one hormone (gonadotrophin) before ovulation. There was no evidence to suggest any benefit of withholding gonadotrophins (coasting) after ovulation in IVF for the prevention of OHSS (ovarian hyperstimulation syndrome) or in live births compared with no coasting or other interventions.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Coasting versus no coasting for preventing ovarian hyperstimulation syndrome 
B A C K G R O U N D
Description of the condition
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic, potentially life threatening condition resulting from excessive ovarian stimulation. Its reported incidence varies from 1% to 10% of in vitro fertilization (IVF) cycles (Forman 1990; Wada 1990; MacDougall 1992) . The incidence of the severe form of OHSS in women undergoing controlled ovarian hyperstimulation for IVF is 0.5% to 2% (Forman 1990; SART 1992 ) with a reported positive correlation between younger age, lack of obesity and OHSS (Navot 1992). In addition, polycystic ovarian syndrome (PCOS) or an ultrasonographic ovarian appearance of polycystic ovaries (presence of multiple, small follicles at the periphery of the ovary with echogenic stroma); establishment of pregnancy during assisted reproduction treatment (ART); human chorionic gonadotrophin (hCG) supplementation of the luteal phase; and high serum estradiol (E2) (> 2500 pg/ml) were reported to be associated with OHSS. OHSS was originally classified as mild, moderate or severe by Rabau et al (Rabau 1967; Schenker 1978) and subsequently modified by Golan et al (Golan 1989) to incorporate ultrasonographic measurement of the stimulated ovaries (Table 1) . Navot 1992 introduced further modification to the above classification by differentiating between the severe and the life threatening form of OHSS (Table 2 ). 
Description of the intervention
Coasting or prolonged coasting may be defined as a process whereby (1) gonadotrophin therapy is discontinued while continuing administration of gonadotrophin-releasing hormone agonist (GnRHa); (2) there is a delay by a variable number of days in administering hCG injection to trigger oocyte maturation prior to oocyte retrieval, until safe estradiol levels are attained (Sher 1993). Coasting should not be initiated too early or too late. Serum estradiol must be allowed to fall, but not to a very low level, before hCG administration. The effective duration of coasting is still to be determined. Many authors believe that each IVF centre should identify its own cut-off limit of serum estradiol or follicle size, or both, at onset of coasting and at the time of hCG administration (Waldenstrom 1999; Al-Shawaf 2001) ( Table 3) . 
How the intervention might work
It was suggested that this approach prevents severe OHSS by removing the follicle stimulating hormone (FSH) stimulation of granulosa cells thereby inhibiting their proliferation and reducing the number of granulosa cells available for luteinization (Sher 1995) . This will allow continued follicular growth and maturation while reducing the risk of OHSS (Fluker 1999) . In addition, Tortoriello 1998 suggested that the falling FSH concentration induces an increased apoptosis of granulosa cells, which results in a reduction of chemical mediators or precursors that augment fluid extravasation. It has also been postulated that follicles of varying size have a different threshold to gonadotrophins and smaller follicles appear to be more susceptible to gonadotrophin deprivation than larger follicles (Fluker 1999). When coasting is initiated prior to 30% of follicles having attained a mean diameter of 15 mm, an abrupt arrest in follicular development and a rapid decline in plasma estradiol usually compromise the oocyte quality. But if most of the follicles are > 15 mm in mean diameter when coasting is implemented, large cystic follicles are commonly encountered and the quality of oocytes is also compromised (Sher 1995).
Why it is important to do this review
OHSS is a potentially life threatening condition associated with super-ovulation in ART. It is therefore important to establish from the scientific literature if coasting can reduce the incidence of this condition.
O B J E C T I V E S
To assess the effect of withholding gonadotrophins (coasting) in the prevention of ovarian hyperstimulation syndrome (OHSS) in assisted reproduction cycles.
M E T H O D S Criteria for considering studies for this review
Types of studies
Only randomised controlled trials (RCTs) in which coasting was used as a preventive strategy to reduce OHSS were included. Ovulation induction treatment without in vitro fertilisation (IVF) or intra-cytoplasmic sperm injection (ICSI) and cross-over trials were not included in this systematic review and meta-analysis.
Types of participants
• Women of reproductive age • Women with PCOS • Women down-regulated by GnRH-a, undergoing superovulation in IVF or ICSI cycles
Types of interventions
Coasting is the withholding of gonadotrophins. A definition is provided under the Description of the intervention section of this report. Early unilateral follicular aspiration involves the aspiration of every visible follicle from one ovary between 10 to 12 hours after the administration of human chorionic gonadotrophin (hCG).
• Coasting when estradiol levels were > 2500 pg/mL or > 9000 pmol/L versus early unilateral follicular aspiration
• Coasting when estradiol levels were > 2500 pg/mL or > 9000 pmol/L versus no coasting or other interventions
Types of outcome measures Primary outcomes
The primary outcomes of this systematic review were:
• incidence of moderate or severe OHSS (refer to Description of the condition) subsequent to oocyte retrieval;
• live birth rate.
Secondary outcomes
The secondary outcomes were:
• clinical pregnancy rate per woman randomised;
• multiple pregnancy rate;
• number of oocytes retrieved;
• number of women admitted to hospital, inpatient versus outpatient;
• number of days to next menstrual period (resolution).
Search methods for identification of studies Electronic searches
The following electronic databases and trial registers were searched (from 2001 in the update of this review to July 2010):
• Cochrane Menstrual Disorders and Subfertility Review Group (MSDSG) Specialised Register of controlled trials (July 2010), Appendix 1;
• CENTRAL (inception to 2010), Appendix 4;
• MEDLINE (2001 to 2010), Appendix 2;
• EMBASE (2001 to 2010), Appendix 3.
The MEDLINE search was combined with the Cochrane highly sensitive search strategy for identifying randomised trials, which appears in the searching chapter of The Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2008). The EM-BASE search was combined with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (www.sign.ac.uk/ methodology/filters.html#random).
Searching other resources
The reference list of articles retrieved by the search was handsearched and personal contact made with the authors regarding any additional data required. Additional handsearching was conducted in journals not included in the MSDSG register.
Data collection and analysis
Selection of studies
Two review authors (NNA and ADA in the original review; ADA and JB in the updated review) scanned the titles and abstracts of the identified studies. Those that were clearly irrelevant were removed. The full texts of potentially relevant articles were retrieved and independently assessed for inclusion by ADA and JB. Disagreement was resolved by consensus.
Data extraction and management
The review authors independently extracted data using forms designed according to Cochrane guidelines. Where studies had multiple publications, the main trial report was used as the reference and additional details supplemented from the additional papers. Authors of the original papers were contacted for additional information, if necessary. Two review authors (ADA and JB) extracted the data independently and any disagreements were resolved by consensus.
Assessment of risk of bias in included studies
The included studies were assessed for risk of bias using the Cochrane risk of bias assessment tool ( Figure 1 ; Figure 2 ) to assess: sequence generation; allocation concealment; blinding of participants, providers and outcome assessors; completeness of outcome data and selective outcome reporting. Two review authors assessed these domains, with disagreements resolved by consensus. The summary is presented in the 'Risk of bias' table (Characteristics of included studies). 
Measures of treatment effect
For dichotomous data, the number of events in the control and intervention groups were used to calculate Mantel Haenszel odds ratios, in a fixed-effect model. For continuous data, mean differences between groups were calculated in a fixed-effect model. The 95% confidence intervals were reported with all treatment effects.
Unit of analysis issues
Data were presented as per woman randomised and not per cycle.
Dealing with missing data
Where more than 20% of participants were lost to follow up or dropped out the data were not included in the meta-analysis. Where data were missing the original authors were contacted for further information. If this was unsuccessful, the missing data may have been imputed or calculated using methods suggested in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2008).
Assessment of heterogeneity
Statistical heterogeneity was assessed using the I 2 statistic (Higgins 2008). If heterogeneity exceeded 50% then subgroup or sensitivity analysis was to be conducted in an attempt to explain the data. Sensitivity analysis might explain why there is heterogeneity in the data. If heterogeneity could not be satisfactorily explained then the data would not be deemed suitable for inclusion in the metaanalysis and would not be pooled.
Assessment of reporting biases
If eight or more original papers were identified then a funnel plot would be produced in an attempt to identify any publication bias.
Data synthesis
For dichotomous data the Mantel Haenszel method was used in the meta-analysis with a fixed-effect model. For continuous data the inverse variance method was used with a fixed-effect model.
Subgroup analysis and investigation of heterogeneity
The planned subgroups that were examined were related to the comparisons with coasting. These were early unilateral follicular aspiration and GnRHa and no coasting.
Sensitivity analysis
Where heterogeneity was high (> 50%) then sensitivity analysis would be conducted based on the quality of the included studies as indicated in the 'Risk of bias' table and whether the data were from a full paper or conference proceedings. Where there were sufficient studies, sensitivity analysis was conducted even if heterogeneity was not high.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies.
Results of the search
Sixteen potential studies were identified. See the tables Characteristics of included studies and Characteristics of excluded studies. All four trials included women at high risk of developing OHSS. Aboulgar 2007 defined this as ≥ 20 follicles on both ovaries, 90% of follicles being < 14 mm mean diameter and E2 ≥ 3000 pg/ ml. Aflatoonian 2006 had the same criteria, although they did not define the mean diameter of follicles. Kamthane, 2007 defined women at risk of OHSS as having follicles > 10 mm in diameter or E2 > 700 pg/ml on day 7 or day 8. Egbase 1999 had an E2 threshold of 6000 pg/ml as a defined risk for OHSS.
Included studies
Excluded studies
Twelve studies were excluded. One was randomised but the control was matched retrospectively (Aboulghar 1998). The other 11 studies were excluded because they were not randomised. Four were prospective observational studies (Sher 1995; Lee 1998; Waldenstrom 1999; Al-Shawaf 2001) . Five were retrospective observational studies (Benadiva 1997; Tortoriello 1998; Fluker 1999; Tortoriello 1999; Ulug 2002) . Two studies were retrospective casecontrol studies (Dhont 1998; VanderStraeten 1998) .
Risk of bias in included studies
See the table 'Characteristics of included studies'. Egbase 1999 reported using computer generated random allocation to the intervention groups. There were no details on the method of randomisation in the other studies. 
Blinding
None of the included studies reported on blinding. Blinding of investigators and women is not possible in these interventions, which are based on timing. Outcome assessors could have been blinded to allocation of intervention.
Incomplete outcome data
All randomised participants were included in the data analyses 
Selective reporting
Aflatoonian 2006 was a conference abstract and did not report outcomes a priori. Kamthane, 2007 summarised the a priori outcomes in their conference abstract. There was no evidence in the literature of a full paper publication for these two studies.
Other potential sources of bias
There were no other sources of bias that were identified.
Effects of interventions
See: Summary of findings for the main comparison Coasting versus no coasting for preventing ovarian hyperstimulation syndrome Summary of findings tables for comparisons with usable data can be referred to in Summary of findings for the main comparison, Table 4 and Table 5 . 1 One of the trials (Aflatoonian, 2006) provided inadequate information on allocation concealment, attrition and the a priori outcomes were not listed 2 One of the included trials is in conference abstract form only and does not appear to have been published as a full paper 3 95%CI includes both no effect and benefit or harm 1 95%CI crosses no effect and substantive benefit or harm
Coasting versus early unilateral follicular aspiration Moderate or severe ovarian hyperstimulation syndrome (OHSS)
Two of the included studies compared coasting (n = 42) with early unilateral follicular aspiration (n = 41) (Egbase 1999; Aflatoonian 2006). There was no evidence of a significant benefit in the reduction in OHSS between the two groups (OR 0.98, 95% CI 0.34 to 2.85; P = 0.97; I 2 = 0%). Refer to Figure 3 . 
Live birth
Live birth was not reported in either trial that compared coasting with early unilateral follicular aspiration (Egbase 1999; Aflatoonian 2006).
Clinical pregnancy
There was no evidence of an effect on the outcome of clinical pregnancy for coasting versus early unilateral follicular aspiration (OR 0.67, 95% CI 0.25 to 1.79; P = 0.42; I 2 = 0%). Refer to Figure 4 . 
Multiple pregnancy
Multiple pregnancy was not reported in either trial that compared coasting with early unilateral follicular aspiration (Egbase 1999; Aflatoonian 2006).
Miscarriage
Miscarriage was not reported in the trials comparing coasting with early unilateral follicular aspiration (Egbase 1999; Aflatoonian 2006).
Number of oocytes retrieved
Both trials comparing coasting with early unilateral follicular aspiration reported on the number of oocytes retrieved (Egbase 1999; Aflatoonian 2006). Heterogeneity was evident (I 2 = 87%) and therefore no meta-analysis was conducted. The heterogeneity may be due to the to differences in the cut off for oestrogen levels in the definition of high risk for OHSS. Aflatoonian 2006 used a cut-off level of > 3000 pg/ml E 2 and Egbase 1999 used a cut-off level of > 6000 pg/ml E 2 . Refer to Figure 5 . One trial compared coasting with GnRHa (Aboulgar 2007). There were no instances of OHSS in either group (n = 190).
Live birth
Live birth was not reported in the trial comparing coasting with GnRHa (Aboulgar 2007).
Clinical pregnancy
There was no evidence of an effect on the outcome of clinical pregnancy for coasting versus GnRHa (OR 0.74, 95% CI 0.42 to 1.31; P = 0.31). Refer to Figure 6 . 
Coasting versus no coasting
The no coasting group had E2 levels of 3000 pg/ml to < 4000 pg/ ml on the hCG day. They had conventional IVF followed by day-2 transfer.
Moderate to severe ovarian hyperstimulation syndrome (OHSS)
One trial compared coasting with no coasting (Kamthane, 2007) . There was evidence of significantly fewer cases of moderate or severe OHSS in the coasting group compared to the no coasting group (OR 0.17, 95% CI 0.03 to 0.88; P = 0.03). Refer to Figure  9 . 
Live birth
One trial reported on live birth (Kamthane, 2007) . There was no evidence of a significant difference between coasting and no coasting for this outcome (OR 0.48, 95% CI 0.14 to 1.62; P = 0.24). Refer to Figure 10 . 
Multiple pregnancy
Multiple pregnancy as an outcome was not reported by Kamthane, 2007 .
Miscarriage
One trial (Kamthane, 2007) reported on miscarriage as an outcome in coasting compared with no coasting. There was no evidence of a difference between the groups (OR 0.65, 95% CI 0.10 to 4.13; P = 0.64).
Number of oocytes retrieved
One trial (Kamthane, 2007) reported on the number of oocytes retrieved. The evidence suggested that significantly fewer oocytes were retrieved in women undergoing coasting than with no coasting (-3.92, 95% CI -4.47 to -3.37; P < 0.00001). Refer to Figure  12 . 
D I S C U S S I O N Summary of main results
The results suggested that there was a significant benefit of coasting over no coasting for a reduction in moderate to severe OHSS. There was no evidence of differences in the incidence of moderate to severe OHSS or in the achievement of clinical pregnancy when coasting was compared with early unilateral follicular aspiration or GnRHa. Nor was there evidence to suggest a benefit in live birth from coasting compared with no coasting, although the data were from a single trial only. It is difficult to draw any conclusions on the number of oocytes obtained due to the statistical heterogeneity of the studies. Nor was there any evidence of differences in multiple pregnancies, live births or miscarriage rates per woman randomised.
Overall completeness and applicability of evidence
Only four trials were identified and two of these were conference abstracts. The completeness and applicability of the data were somewhat limited by this factor. Only one of the trials reported on the outcome of live birth. There may be additional interventions which have not as yet been compared with coasting in a randomised controlled trial.
Quality of the evidence
The four trials reported on outcomes for 273 women. Two of the trials were conference abstracts. No evidence of full publication of the data was identified since the abstracts were published, in 2006 (Aflatoonian 2006 ) and 2007 (Kamthane, 2007 . Three to four years is longer than expected to publish a full paper. The fact that the data from the trials were only presented in abstract form makes assessment of quality difficult, due to lack of details. With the exception of the number of oocytes retrieved the statistical heterogeneity between studies was acceptable.
Potential biases in the review process
The authors attempted to identify all potential studies using a variety of methods. One of the main biases as mentioned above is that several of the trials were only published as conference abstracts.
There may be other relevant data which have not been reported. The results of the systematic review must therefore be interpreted with caution.
Agreements and disagreements with other studies or reviews
No non-randomised trial identified (Characteristics of excluded studies) found evidence of a difference in clinical pregnancy rate. In these excluded studies the higher the oestrogen level at the beginning of coasting the less effective the intervention was at preventing OHSS, irrespective of the duration of the coasting period (Sher 1995; Aboulghar 1998; Dhont 1998; Lee 1998; Fluker 1999; Waldenstrom 1999) . The inclusion criterion for this systematic review was oestrogen levels > 2500 pg/ml. The four included trials used a cut off > 3000 pg/ml and this may in part explain the lack of effect.
A U T H O R S ' C O N C L U S I O N S Implications for practice
The evidence suggests that there is no benefit in withholding gonadotrophins (coasting) for live birth or the clinical pregnancy rate. There was a benefit in favour of coasting for reduced moderate to severe OHSS when compared with no coasting, although no benefit was observed when coasting was compared with early unilateral follicular aspiration or gonadotrophin-releasing hormone agonist (GnRHa). Therefore, at present clinicians should employ strategies which appear to result in a lower incidence of severe OHSS rather than coasting until further evidence has accumulated. Strategies include human intra-venous albumin administration around the time of oocyte retrieval.
Implications for research
There is a need to compare more established treatments such as intra-venous albumin infusion or cryopreservation of all embryos, which do not require the additional surgical intervention with coasting. The trials should involve an appropriate number of participants to demonstrate a statistical difference between the treatments and should be appropriately blinded in the random allocation. Women should enter the study when they are considered at risk of developing OHSS according to common criteria for OHSS classification.
A C K N O W L E D G E M E N T S
The authors wish to thank the Menstrual Disorders and Subfertility Group editorial office staff for their advice and support through the review process.
R E F E R E N C E S C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Aboulgar 2007
Methods Randomised controlled trial, single centre. Interventions Group A (n=16) early coasting from day 8 onwards on basis of high E2 (> 700pg/ml). Group B (n=18) late coasting when one of the follicles reached 15mm; E2 < 700pg/ml on day 8 but number of intermediate follicles were more than 10. Group C (n=34) no coasting, E2 level on 3000pg/ml to < 4000pg/ml hCG day. These women neither had E2 > 700pg/ml nor intermediate follicles > 10mm.
Outcomes OHSS severity, terminal E2 mean number of oocytes retrieved, endometrial thickness, clinical pregnancy, miscarriage, live birth.
Notes
Women with E2 > 4000pg/ml on hCG day had transvaginal ovum retrieval and following fertilization the embryos were frozen and not transferred in that cycle. These women received prophylactic IV albumin and were excluded from the study. 
Risk of bias
